Product Information
AROMASIN 25 MG TABLET is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $38.9792 per EA under NDC 00009766304. Its NADAC has been published 383 times since Nov 28, 2013.
FDA first approved this application on Oct 21, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the exemestane market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009766304
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
EXEMESTANEApproval Type
New Drug (NDA)
FDA Application
NDA020753FDA Approved
10/21/1999
TE Code
AB
On Market Since
10/21/1999
Pharmacological Classes
Price Statistics
The NADAC for AROMASIN 25 MG TABLET has been published 383 times since Nov 28, 2013, and over the history we have for it it has risen 146.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $38.9792 per EA |
|---|---|
| All-time high | $38.9792 (Aug 19, 2026) |
| All-time low | $15.7931 (Nov 28, 2013) |
| 52-week high | $38.9792 |
| 52-week low | $36.6728 |
| Median price | $32.0576 |
| Average price | $29.6303 |
| Largest weekly change | +9.4% (Jun 7, 2017) |
| Weeks tracked | 383 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AROMASIN 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AROMASIN 25 MG TABLET, manufactured by Pharmacia & Upjohn Company LLC, is $38.9792 per EA (NDC 00009766304), effective Aug 19, 2026.
How has the price of AROMASIN 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for AROMASIN 25 MG TABLET has risen 146.8%. It has been tracked across 383 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AROMASIN 25 MG TABLET?
Since Nov 28, 2013, the NADAC for AROMASIN 25 MG TABLET has ranged from a low of $15.7931 (Nov 28, 2013) to a high of $38.9792 (Aug 19, 2026), with a median of $32.0576 per EA.
Are there cheaper alternatives to AROMASIN 25 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EXEMESTANE 25 MG TABLET, is $0.7177 per EA — about 98% below AROMASIN 25 MG TABLET.
Who manufactures AROMASIN 25 MG TABLET?
AROMASIN 25 MG TABLET (NDC 00009766304) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.